Simulations Plus Inc (SLP)

May 21, 2026

Simulations Plus to Participate in the 23rd Annual Craig-Hallum Institutional Investor Conference - Business Wire

May 21, 2026

May 18, 2026

SLP Stock Price, Quote & Chart | SIMULATIONS PLUS INC (NASDAQ:SLP) - ChartMill

May 18, 2026

May 15, 2026

(SLP) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily

May 15, 2026

May 13, 2026

Simulations Plus president sells $16,530 in company stock - Investing.com UK

May 13, 2026

May 13, 2026

Simulations Plus president sells $16,530 in company stock By Investing.com - Investing.com India

May 13, 2026

May 13, 2026

Simulations Plus (SLP) executive exercises options and sells 1,000 shares under 10b5-1 plan - Stock Titan

May 13, 2026

May 12, 2026

TradingKey - TradingKey

May 12, 2026

May 11, 2026

[144] Simulations Plus, Inc. SEC Filing - Stock Titan

May 11, 2026

May 11, 2026

Nicholas Company Inc. Buys 78,854 Shares of Simulations Plus, Inc. $SLP - MarketBeat

May 11, 2026

May 08, 2026

NVIDIA Pushes AI Into Drug Development With Simulations Plus Collaboration - Yahoo Finance

May 08, 2026

May 08, 2026

Simulations Plus unveils method for QST model integration with microphysiological data in liver risk analysis - Traders Union

May 08, 2026

May 08, 2026

Simulations Plus collaborates with NVIDIA during AI drug modeling push - MSN

May 08, 2026

May 08, 2026

Simulations Plus, Inc. (SLP): Investor Outlook With A 47% Potential Upside - DirectorsTalk Interviews

May 08, 2026

May 08, 2026

Simulations Plus (SLP) Partners with NVIDIA for Advanced Drug De - GuruFocus

May 08, 2026

May 07, 2026

Simulations Plus teams with NVIDIA on drug modeling - Engineering.com

May 07, 2026

May 07, 2026

Simulations Plus (NASDAQ:SLP) Stock Price Crosses Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat

May 07, 2026

May 06, 2026

Simulations Plus Collaborates With Nvidia During AI Drug Modeling Push - Dailyhunt

May 06, 2026

May 06, 2026

Simulations Plus and NVIDIA Collaborate to Scale GPU-Accelerated, AI-Assisted Modeling Workflows - HPCwire

May 06, 2026

May 06, 2026

Simulations Plus partners with Nvidia on AI drug development By Investing.com - Investing.com India

May 06, 2026

May 06, 2026

Simulations Plus partners with Nvidia on AI drug development - Investing.com

May 06, 2026

May 06, 2026

Simulations Plus stock surges 28% on NVIDIA collaboration - Investing.com

May 06, 2026

May 06, 2026

Simulations Plus And NVIDIA Collaborate To Scale GPU-Accelerated, AI-Assisted Modeling Workflows - marketscreener.com

May 06, 2026

May 06, 2026

Simulations Plus stock surges 28% on NVIDIA collaboration By Investing.com - Investing.com Canada

May 06, 2026

May 05, 2026

Insider Sell Alert: DiBella John Anthony II Sells Shares of Simu - GuruFocus

May 05, 2026

May 05, 2026

[Form 4] Simulations Plus, Inc. Insider Trading Activity - Stock Titan

May 05, 2026

May 05, 2026

Simulations Plus (SLP) insiders sell 15,000 shares in planned trade - Stock Titan

May 05, 2026

May 05, 2026

Do options traders know something about Simulations Plus stock we don't? - MSN

May 05, 2026

May 04, 2026

(SLP) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

May 04, 2026

May 04, 2026

Do Options Traders Know Something About Simulations Plus Stock We Don't? - TradingView

May 04, 2026

May 01, 2026

Simulations Plus (SLP) director receives 2,117-share equity grant as compensation - Stock Titan

May 01, 2026

May 01, 2026

Director Sharlene Evans receives 2,117 SLP shares in equity grant - Stock Titan

May 01, 2026

May 01, 2026

Director at Simulations Plus (SLP) receives 2,117-share stock grant - Stock Titan

May 01, 2026

May 01, 2026

Simulations Plus (SLP) director awarded 2,117 shares as equity compensation - Stock Titan

May 01, 2026

Apr 29, 2026

AI in Predictive Toxicology Research Report 2026 Featuring - GlobeNewswire

Apr 29, 2026

Apr 29, 2026

AI in Predictive Toxicology Research Report 2026 Featuring Certara, Schrodinger, Instem, Simulations Plus, Lhasa, ChemaxonGlobal Forecast to 2030 and 2035 - Yahoo Finance UK

Apr 29, 2026

Apr 27, 2026

Global Biosimulation Market Poised for Phenomenal Expansion at a CAGR of ~17% by 2034 | DelveInsight - GlobeNewswire Inc.

Apr 27, 2026

Apr 27, 2026

Simulations Plus, Inc. (NASDAQ:SLP) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat

Apr 27, 2026

Apr 26, 2026

Latest SLP NewsSimulations Plus Announces Quarterly Cash Di... - Stock Titan

Apr 26, 2026

Apr 26, 2026

Simulations Plus Q2 2026 earnings preview - MSN

Apr 26, 2026

Apr 23, 2026

Certara Strategic Business Divestiture Comes At Right Time, Says Analyst - Sahm

Apr 23, 2026

Apr 23, 2026

(SLP) Risk Channels and Responsive Allocation - Stock Traders Daily

Apr 23, 2026

Apr 23, 2026

Simulations Plus shares drop over 12% premarket as Q3 revenue forecast misses expectations - MSN

Apr 23, 2026